See All Slides - tctmd.com

Slides

Presentation TCT 2023

M-TEER in Decompensated Heart Failure: Indications, Timing, and Challenges

Presenter: Saibal Kar

October 25, 2023

Presentation TCT 2023

Long-term Clinical Outcomes After iFR vs. FFR Guided Coronary Revascularization – Insights From the SWEDEHEART National Registry

Presenter: Matthias Götberg

October 25, 2023

Presentation TCT 2023

STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors

Presenter: Sanjit Jolly

October 25, 2023

Presentation TCT 2023

Pantera Lux

Presenter: Ron Waksman

October 25, 2023

Presentation TCT 2023

TCT 244: Impact of Online Educational Series on Interventional Innovations in Blood Pressure Control

Presenter: Ron miller

October 25, 2023

Presentation TCT 2023

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

Presenter: Eline Ploumen

October 25, 2023

Presentation TCT 2023

TCT 84: The Significance of Final Corrected TIMI Frame Count in the Management of No-Reflow during Primary Percutaneous Coronary Intervention (PPCI).

Presenter: Kamran Khan

October 25, 2023

Presentation TCT 2023

TCT 386: Sapien 3 in Degenerated Calcified Evolut: Assessing Hydrodynamic Function and Leaflet Kinematics After Redo-TAVR

Presenter: Janarthanan Sathananthan

October 25, 2023

Presentation TCT 2023

TCT 201: Impact of Mismatch between Mitral Valve Regurgitation and Left Atrial Pressure after Transcatheter Mitral Valve Repair on Prognosis: Insights from the OCEAN-Mitra Registry

Presenter: Eiji Shibahashi

October 25, 2023

Presentation TCT 2023

TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial

Presenter: Minju Han

October 25, 2023

Advertisement

Slides

M-TEER in Decompensated Heart Failure: Indications, Timing, and Challenges

Long-term Clinical Outcomes After iFR vs. FFR Guided Coronary Revascularization – Insights From the SWEDEHEART National Registry

STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors

Pantera Lux

TCT 244: Impact of Online Educational Series on Interventional Innovations in Blood Pressure Control

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

TCT 84: The Significance of Final Corrected TIMI Frame Count in the Management of No-Reflow during Primary Percutaneous Coronary Intervention (PPCI).

TCT 386: Sapien 3 in Degenerated Calcified Evolut: Assessing Hydrodynamic Function and Leaflet Kinematics After Redo-TAVR

TCT 201: Impact of Mismatch between Mitral Valve Regurgitation and Left Atrial Pressure after Transcatheter Mitral Valve Repair on Prognosis: Insights from the OCEAN-Mitra Registry

TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content